Preview

PDF 2021-09_Brueckn...pdf | Download (1MB) | Preview

Abstract

This paper studies the role of capitalization on firms’ stock price growth in response to new
cases of Covid-19 infections in the United States. Controlling for firm and time fixed effects,
our panel model estimates show that the effect of new cases of Covid-19 infections on firms’
stock price growth is significantly increasing in capitalization: For each one standard deviation
increase in capitalization, a one standard deviation increase in new cases of Covid-19 infections
increases the weekly growth rate of firms’ stock prices by about 0.7 percentage points. Effects
of capitalization on the impact that Covid-19 infections have on firms’ stock price growth are
largest in the travel, tourism, and hospitality sector. Smaller but still positive effects of
capitalization are present in the pharmaceutical products, high-tech, and banking and finance
sectors.

Item Type:	Report (Discussion Paper)
Authors/Creators:	Brueckner, M and Kang, W and Vespignani, JL
Keywords:	Covid-19, performance of firms, stock market capitalization, U.S. stock market
Publisher:	University of Tasmania
Copyright Information:	Copyright 2021 University of Tasmania
Additional Information:	Discussion Paper Series N 2021-09 JEL Classification: G10, E30
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page